Cationic lipids activate intracellular signaling pathways

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256

Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

Cros, J. F., Cagnard, N., Woollard, K. J., Patey, N., Zhang, S., Sénéchal, B., Puel, A., Biswas, S. K., Moshous, D., Pïcard, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.012 · Cited by 1,320

Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery

Khalil, I. A., Kogure, K., Akita, H., & Harashima, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.8 · Cited by 1,263

Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,

Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136

CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4

Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997

The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4

Mata‐Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 901

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoît, J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 786

The inflammasome: an integrated view

Gross, O., Thomas, C. J., Guarda, G., & Tschopp, J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01046.x · Cited by 778

CD14 is required for MyD88-independent LPS signaling

Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., et al. (2005) · Nature Immunology · doi:10.1038/ni1207 · Cited by 683

Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome

Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Theelen, B., van der Vlist, M., Boekhout, T., & Geijtenbeek, T. B. H. (2012) · Nature Immunology · doi:10.1038/ni.2222 · Cited by 628

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

Ndeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H., & Igyártó, B. Z. (2021) · iScience · doi:10.1016/j.isci.2021.103479 · Cited by 678

Lipids and Lipid Derivatives for RNA Delivery

Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 649

Liposomes as vaccine delivery systems: a review of the recent advances

Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 524

The dawn of mRNA vaccines: the COVID-19 case

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection

Xu, S., Yang, K., Li, R., & Zhang, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186582 · Cited by 368

Circular RNA vaccine in disease prevention and treatment

Niu, D., Wu, Y., & Lian, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01561-x · Cited by 281

mRNA vaccines in disease prevention and treatment

Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 273

Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release

Aghdam, M. A., Bagheri, R., Mosafer, J., Baradaran, B., Hashemzaei, M., Baghbanzadeh, A., de la Guárdia, M., & Mokhtarzadeh, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.018 · Cited by 242

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines

Aldosari, B. N., Alfagih, I. M., & Almurshedi, A. S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020206 · Cited by 248

Mechanism of action of mRNA-based vaccines

Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1355245 · Cited by 234

Microenvironment-responsive immunoregulatory electrospun fibers for promoting nerve function recovery

Xi, K., Gu, Y., Tang, J., Chen, H., Xu, Y., Wu, L., Cai, F., Deng, L., Yang, H., Shi, Q., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18265-3 · Cited by 231

Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging

Lindsay, K. E., Bhosle, S. M., Zurla, C., Beyersdorf, J., Rogers, K. A., Vanover, D., Xiao, P., Araínga, M., Shirreff, L. M., Pitard, B., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0378-3 · Cited by 218

Materials for Immunotherapy

Shields, C. W., Wang, L., Evans, M. A., & Mitragotri, S. (2019) · Advanced Materials · doi:10.1002/adma.201901633 · Cited by 194

Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery

Raemdonck, K., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60299k · Cited by 192

How cationic lipids transfer nucleic acids into cells and across cellular membranes: Recent advances

Rehman, Z. U., Zuhorn, I. S., & Hoekstra, D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.014 · Cited by 194

Clinical and immunological effects of mRNA vaccines in malignant diseases

Heine, A., Juranek, S., & Brossart, P. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01339-1 · Cited by 186

Correlation of the cytotoxic effects of cationic lipids with their headgroups

Cui, S., Wang, Y., Gong, Y., Lin, X., Zhao, Y., Zhi, D., Zhou, Q., & Zhang, S. (2018) · Toxicology Research · doi:10.1039/c8tx00005k · Cited by 180

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing

Qiu, M., Li, Y., Bloomer, H., & Xu, Q. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00500 · Cited by 168

Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint

Granot-Matok, Y., & Peer, D. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.015 · Cited by 160

Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential

Kheraldine, H., Rachid, O., Habib, A. M., Moustafa, A. A., Benter, I. F., & Akhtar, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113908 · Cited by 152

Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal delivery

Weijer, R., Broekgaarden, M., Kos, M., van Vught, R., Rauws, E. A., Breukink, E. J., van Gulik, T. M., Storm, G., & Heger, M. (2015) · Journal of Photochemistry and Photobiology C Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2015.05.002 · Cited by 141

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines

Lee, J., Woodruff, M. C., Kim, E. H., & Nam, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00999-x · Cited by 141

Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications

Yuba, E. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02470k · Cited by 134

Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways

Lonez, C., Bessodes, M., Scherman, D., Vandenbranden, M., Escriou, V., & Ruysschaert, J. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.003 · Cited by 129

The immunostimulatory nature of mRNA lipid nanoparticles

Sharma, P., Hoorn, D., Aitha, A., Breier, D., & Peer, D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115175 · Cited by 132

Nanovaccine: an emerging strategy

Das, A., & Ali, N. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1984890 · Cited by 132

Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy

Yoshizaki, Y., Yuba, E., Sakaguchi, N., Koiwai, K., Harada, A., & Kono, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.077 · Cited by 123

A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens

Swaminathan, G., Thoryk, E. A., Cox, K. S., Meschino, S., Dubey, S. A., Vora, K. A., Celano, R., Gindy, M. E., Casimiro, D. R., & Bett, A. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.132 · Cited by 118

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112

Future considerations for the mRNA-lipid nanoparticle vaccine platform

Igyártó, B. Z., Jacobsen, S., & Ndeupen, S. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.03.008 · Cited by 108

Mucosal Vaccine Development Based on Liposome Technology

Bernasconi, V., Norling, K., Bally, M., Höök, F., & Lycke, N. Y. (2016) · Journal of Immunology Research · doi:10.1155/2016/5482087 · Cited by 111

Nanotools for Sepsis Diagnosis and Treatment

Papafilippou, L., Claxton, A., Dark, P., Kostarelos, K., & Hadjidemetriou, M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001378 · Cited by 118

Lipid nanocarriers for microRNA delivery

Scheideler, M., Vidaković, I., & Prassl, R. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104837 · Cited by 111

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases

Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104

Modulation of Immune Response Using Engineered Nanoparticle Surfaces

Moyano, D. F., Liu, Y., Peer, D., & Rotello, V. M. (2015) · Small · doi:10.1002/smll.201502273 · Cited by 107

Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4

Zelkoski, A. E., Lu, Z., Sukumar, G., Dalgard, C. L., Said, H., Alameh, M., Mitre, E. E. S., & Malloy, A. M. W. (2025) · npj Vaccines · doi:10.1038/s41541-025-01124-x · Cited by 117

Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs

Li, Y., Ye, Z., Yang, H., & Xu, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.04.013 · Cited by 103

Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors

Junquera, E., & Aicart, E. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.07.003 · Cited by 99

pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA

Yoshizaki, Y., Yuba, E., Sakaguchi, N., Koiwai, K., Harada, A., & Kono, K. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.001 · Cited by 90

Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives

Kiaie, S. H., Mojarad-Jabali, S., Khaleseh, F., Allahyari, S., Taheri, E., Zakeri-Milani, P., & Valizadeh, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119269 · Cited by 87

Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends

Badiee, A., Shargh, V. H., Khamesipour, A., & Jaafari, M. R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.068 · Cited by 86

Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview

Romerio, A., & Peri, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01210 · Cited by 84

Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System

Catenacci, L., Rossi, R., Sechi, F., Buonocore, D., Sorrenti, M., Perteghella, S., Peviani, M., & Bonferoni, M. C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121521 · Cited by 86

Microfluidic self-assembly of folate-targeted monomolecular siRNA-lipid nanoparticles

Krzysztoń, R., Salem, B., Lee, D.-J., Schwake, G., Wagner, E., & Rädler, J. O. (2017) · Nanoscale · doi:10.1039/c7nr01593c · Cited by 82

Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model

Markov, O. V., Mironova, N. L., Shmendel, E. V., Serikov, R. N., Morozova, N. G., Maslov, M. A., Vlassov, V. V., & Аркадьевна, З. М. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.028 · Cited by 78

Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines

Li, Z., Zhang, X., Ho, W., Li, F., Gao, M., Bai, X., & Xu, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c07822 · Cited by 79

The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs)

Hwang, T., Aljuffali, I. A., Hung, C., Chen, C., & Fang, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.011 · Cited by 73

New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy

Kumar, K., Rani, V., Mishra, M., & Chawla, R. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100103 · Cited by 72

Engineering of small interfering RNA-loaded lipidoid-poly( DL -lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach

Thanki, K., Zeng, X., Justesen, S., Tejlmann, S., Falkenberg, E., Driessche, E. V., Nielsen, H. M., Franzyk, H., & Foged, C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.07.014 · Cited by 71

Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction

Vhora, I., Lalani, R., Bhatt, P., Patil, S., & Misra, A. R. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.006 · Cited by 70

Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids

Allen, R., & Yokota, T. (2024) · Molecules · doi:10.3390/molecules29245997 · Cited by 62

Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice

Moreno, E., Schwartz, J., Larrea, E., Conde, I., Font, M., Sanmartín, C., Irache, J. M., & Espuelas, S. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.011 · Cited by 62

Liposome-based immunity-inducing systems for cancer immunotherapy

Yuba, E. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.001 · Cited by 63

The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system

Bernard, M., Bazin, E., Petiot, N., Lemdani, K., Commandeur, S., Verdelet, C., Margot, S., Perkov, V., Ripoll, M., Garinot, M., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.004 · Cited by 63

RNA vaccines for cancer: Principles to practice

Guasp, P., Reiche, C., Sethna, Z. M., & Balachandran, V. P. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.005 · Cited by 64

Development and applications of mRNA treatment based on lipid nanoparticles

Wang, Z., Ma, W., Fu, X., Qi, Y., Zhao, Y., & Zhang, S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108130 · Cited by 57

Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis

Korzun, T., Moses, A. S., Jozić, A., Grigoriev, V., Newton, S., Kim, J., Diba, P., Sattler, A. L., Levasseur, P. R., Le, N., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c05088 · Cited by 64

The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatoryPreprint

Ndeupen, S., Qin, Z., Jacobsen, S., Estanbouli, H., Bouteau, A., & Igyártó, B. Z. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.04.430128 · Cited by 57

Non-Viral Nanosystems for Gene and Small Interfering RNA Delivery to the Central Nervous System: Formulating the Solution

O’Mahony, A., Godinho, B. M. D. C., Cryan, J. F., & O’Driscoll, C. M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23672 · Cited by 56

Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy

Karmacharya, P., Patil, B. R., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00569-9 · Cited by 54

Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery

Saiding, Q., Zhang, Z., Chen, S., Xiao, F., Chen, Y., Li, Y., Zhen, X., Khan, M. M., Chen, W., Koo, S., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115116 · Cited by 59

Systemic tumor-specific gene delivery

Kullberg, M., McCarthy, R., & Anchordoquy, T. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.300 · Cited by 51

Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts

He, Z., Wei, X., Luo, M., Luo, S., Yang, Y., Yu, Y.-Y., Chen, Y., Ma, C., Liang, X., Guo, F., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.015 · Cited by 52

PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania

Santos, D. M., Carneiro, M. W., de Moura, T. R., Soto, M., Luz, N. F., Prates, D. B., Irache, J. M., Brodskyn, C. I., Barral, A. M. P., Barral‐Netto, M., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.003 · Cited by 50

Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications

Michel, T., Luft, D., Abraham, M.-K., Reinhardt, S., Medina, M. L. S., Kurz, J., Schaller, M., Avci‐Adali, M., Schlensak, C., Peter, K., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.07.013 · Cited by 51

Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model

Nascimento, T. L., Hillaireau, H., Vergnaud, J., Rivano, M., Deloménie, C., Courilleau, D., Arpicco, S., Suk, J. S., Hanes, J. S., & Fattal, E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.125 · Cited by 49

Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles

Subramaniam, S., Joyce, P., Donnellan, L., Young, C., Wignall, A. D., Hoffmann, P., & Prestidge, C. A. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.03.048 · Cited by 50

A Novel Liposome-Based Nanocarrier Loaded with an LPS-dsRNA Cocktail for Fish Innate Immune System Stimulation

Ruyra, À., Cano‐Sarabia, M., MacKenzie, S. A., Maspoch, D., & Roher, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076338 · Cited by 48

Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface

Lonez, C., Irvine, K. L., Pizzuto, M., Schmidt, B. I., Gay, N. J., Ruysschaert, J., Gangloff, M., & Bryant, C. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1915-1 · Cited by 46

Cationic Nanoparticle-Based Cancer Vaccines

Heuts, J., Jiskoot, W., OSSENDORP, F. A., & van der Maaden, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050596 · Cited by 46

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants

Wong, P. T., Leroueil, P. R., Smith, D. M., Ciotti, S., Bielinska, A. U., Janczak, K. W., Mullen, C. H., Groom, J. V., Taylor, E. M., Passmore, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126120 · Cited by 45

Nanoparticle Platforms for Antigen-Specific Immune Tolerance

Thorp, E. B., Boada, C., Jarbath, C., & Luo, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00945 · Cited by 45

Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis

Moreno, E., Schwartz, J., Fernández-Rubio, C., Sanmartín, C., Nguewa, P., Irache, J. M., & Espuelas, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.885500 · Cited by 45

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events

Giannotta, G., Murrone, A., & Giannotta, N. (2023) · Vaccines · doi:10.3390/vaccines11040747 · Cited by 45

A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development

Huggins, C., Pearce, S. W. A., Peri, F., Neumann, F., COCKERILL, G. W., & Pirianov, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.010 · Cited by 45

Decationized crosslinked polyplexes for redox-triggered gene delivery

Novo, L., van Gaal, E. V. B., Mastrobattista, E., van Nostrum, C. F., & Hennink, W. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.035 · Cited by 44

The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B

Lu, T., Hu, F., Yue, H., Yang, T., & Ma, G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.039 · Cited by 45

Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy

Novo, L., Rizzo, L. Y., Golombek, S. K., Dakwar, G. R., Lou, B., Remaut, K., Mastrobattista, E., van Nostrum, C. F., Jahnen‐Dechent, W., Kiessling, F. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.028 · Cited by 45

Regulation of vascular smooth muscle cell autophagy by DNA nanotube-conjugated mTOR siRNA

You, Z., Qian, H., Wang, C., He, B., Yan, J., Mao, C., & Wang, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.015 · Cited by 42

Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines

Rohde, C. M., Lindemann, C., Giovanelli, M. A., Sellers, R. S., Diekmann, J., Choudhary, S., Ramaiah, L., Vogel, A. B., Chervona, Y., Muik, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11020417 · Cited by 44

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design

de Groot, A. M., Thanki, K., Gangloff, M., Falkenberg, E., Zeng, X., Bijnen, D. C. J. V., van Eden, W., Franzyk, H., Nielsen, H. M., Broere, F., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.02.003 · Cited by 42

Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes

Arya, S., Lin, Q., Zhou, N., Gao, X., & Huang, J.-D. (2020) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.12.044 · Cited by 39

Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles

Calabrese, V., Cighetti, R., & Peri, F. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.011 · Cited by 37

Colloidally Stable Small Unilamellar Stearyl Amine Lipoplexes for Effective BMP-9 Gene Delivery to Stem Cells for Osteogenic Differentiation

Vhora, I., Lalani, R., Bhatt, P., Patil, S., Patel, H., Patel, V., & Misra, A. R. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1161-6 · Cited by 37

Is the oral microbiome a source to enhance mucosal immunity against infectious diseases?

Zenobia, C., Herpoldt, K., & Freire, M. (2021) · npj Vaccines · doi:10.1038/s41541-021-00341-4 · Cited by 40

Cationic lipophosphoramidates with two disulfide motifs: synthesis, behaviour in reductive media and gene transfection activity

Fraix, A., Gall, T. L., Berchel, M., Denis, C., Lehn, P., Montier, T., & Jaffrès, P. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob27261c · Cited by 36

Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed

Ando, H., Kobayashi, S., Lila, A. S. A., Eldin, N. E., Kato, C., Shimizu, T., Ukawa, M., Kawazoe, K., & Ishida, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.019 · Cited by 36

Nonviral Gene Delivery with Dendritic Self-Assembling Architectures

Tschiche, A., Malhotra, S., & Haag, R. (2014) · Nanomedicine · doi:10.2217/nnm.14.32 · Cited by 34

Design of pH-sensitive polymer-modified liposomes for antigen delivery and their application in cancer immunotherapy

Yuba, E. (2016) · Polymer Journal · doi:10.1038/pj.2016.31 · Cited by 34

Cationic Nanostructures for Vaccines Design

Carmona‐Ribeiro, A. M., & Pérez-Betancourt, Y. (2020) · Biomimetics · doi:10.3390/biomimetics5030032 · Cited by 33

Lysine-containing cationic liposomes activate the NLRP3 inflammasome: Effect of a spacer between the head group and the hydrophobic moieties of the lipids

Li, T., He, J., Horvath, G. L., Próchnicki, T., Latz, E., & Takeoka, S. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.011 · Cited by 33

Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies

Sousa, C., & Videira, M. (2025) · Onco · doi:10.3390/onco5010002 · Cited by 39

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review

Ladak, R. J., He, A. J., Huang, Y.-H., & Ding, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885371 · Cited by 35

Vaccination of sheep with a methanogen protein provides insight into levels of antibody in saliva needed to target ruminal methanogens

Subharat, S., Shu, D., Zheng, T., Buddle, B. M., Kaneko, K., Hook, S., Janssen, P. H., & Wedlock, D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159861 · Cited by 32

Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators

Rodríguez-Lavado, J., Sestito, S. E., Cighetti, R., Moncayo, E. M. A., Oblak, A., Lainšček, D., Blanco, J. L. J., Fernández, J. M. G., Mellet, C. O., Jerala, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501182w · Cited by 32

Cationic liposomes evoke proinflammatory mediator release and neutrophil extracellular traps (NETs) toward human neutrophils

Hwang, T., Hsu, C., Aljuffali, I. A., Chen, C.-H., Chang, Y.-T., & Fang, J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.022 · Cited by 32

Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma

Jahani, V., Yazdani, M., Badiee, A., Jaafari, M. R., & Arabi, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.034 · Cited by 33

Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2

Călina, D. C., Hernández, A. F., Härtung, T., Egorov, A. M., Izotov, B. N., Νikolouzakis, Τ. Κ., Tsatsakis, A. M., Vlachoyiannopoulos, P. G., & Docea, A. O. (2021) · Life · doi:10.3390/life11090907 · Cited by 31

Self-assembled triangular DNA nanoparticles are an efficient system for gene delivery

Wang, Y., You, Z., Du, J., Li, H., Chen, H., Li, J., Dong, W., He, B., Mao, C., & Wang, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.038 · Cited by 30

Cationic liposomal lipids: From gene carriers to cell signaling

Lonez, C., Vandenbranden, M., & Ruysschaert, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.03.002 · Cited by 208

Cationic lipids activate cellular cascades. Which receptors are involved?

Lonez, C., Lensink, M. F., Vandenbranden, M., & Ruysschaert, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.02.015 · Cited by 24

A New Class of Lipidic Immunomodulators that Activate TLR-Dependent Cascades and Cytokine Secretion

Lonez, C., Vandenbranden, M., & Ruysschaert, J. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.12.2342

Lipides cationiques impliqués dans le transfert de gène augmentent le niveau de calcium

Ouali, M. (2007) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)

Cationic lipids involved in gene transfer increase intracellular calcium level

Ouali, M., & Ruysschaert, J. M. (2007)